Walgreens’ executive vice president and global chief medical officer, Kevin Ban, shared consumer research findings as well as pharmacy offerings ahead of the fall and winter respiratory season.
Beyfortus is used for the prevention of respiratory syncytial virus lower respiratory tract disease in newborns and infants born during or entering their first RSV season.